SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology

ObjectiveSerology could help to define the real extent of SARS-CoV-2 diffusion, especially in individuals considered at higher risk of COVID-19, such as spondyloarthritis (SpA) patients undergoing immunosuppressant. Our aim was to detect, by serology, previous SARS-CoV-2 contact in SpA, compared to...

Full description

Bibliographic Details
Main Authors: Augusta Ortolan, Mariagrazia Lorenzin, Chiara Cosma, Giacomo Cozzi, Andrea Padoan, Andrea Doria, Mario Plebani, Roberta Ramonda
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
spondyloarthritis
SARS-CoV-2
COVID-19
serology
immunosuppression
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.682850/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.682850/full

Similar Items